Cited by 360Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The amyloid hypothesis on trial

Open access
Makin, Simon·2018·Nature

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/d41586-018-05719-4

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The amyloid cascade hypothesis remains controversial, facing challenges in explaining diverse pathological features, showing weak correlation between Aβ and cognitive decline, and failing to demonstrate efficacy in numerous clinical drugs targeting Aβ.

    “Of note, the amyloid cascade hypothesis remains controversial. This theory faces challenges in explaining the diverse pathological features, shows a weak correlation between Aβ and cognitive decline, and has failed to demonstrate efficacy in numerous clinical drugs to target Aβ.118,144–147”
  • Genetic association studies of late-onset AD identified risk factors such as APOE that modulate Aβ processing, trafficking, and clearance.

    “Subsequent genetic association studies of LOAD bolstered this framework, identifying risk factors such as APOE that modulate Aβ processing, trafficking, and clearance [19, 20, 30].”
  • Repeated failures of Aβ-targeting drugs have brought the amyloid hypothesis under fire.

    “Yet, the repeated failures of these drugs have brought the amyloid hypothesis under fire [19, 31, 34].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Makin, S.
Corresponding author
Makin, Simon
Venue
Nature
Published
2018-07-25
Volume
559
Issue
7715
Pages
S4-S7
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2884933563
Cited by
360
References
14
Citations by year
2026: 13 · 2025: 15 · 2024: 32 · 2023: 55 · 2022: 62 · 2021: 69 · 2020: 68 · 2019: 38 · 2018: 7
FWCI
30.25
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
amyloid hypothesis, Alzheimer's disease, pathogenesis, amyloid-beta, Alzheimer's disease treatment
MeSH terms
Aged, Alzheimer Disease, Animals, Anti-Bacterial Agents, Antiviral Agents, Apolipoproteins E, Humans, Models, Biological, Reproducibility of Results, Amyloid beta-Peptides, tau Proteins, Treatment Failure, Disease Progression, Mice, Plaque, Amyloid, Protein Aggregation, Pathological

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review